NewsPronto

 
Men's Weekly

.

ACN Newswire

Read more press releases from ACN Newswire here

Eisai to Present Data on Oncology Pipeline and Products at ASCO20 Annual Meeting

  • Written by ACN Newswire

image

TOKYO, May 14, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that presentations on a series of abstracts regarding its in-house discovered lenvatinib mesylate (multikinase inhibitor, product name: LENVIMA , "lenvatinib") and eribulin mesylate (halichondrin class microtubule dynamics inhibitor, product name: HALAVEN , "eribulin") will be...

Read more: Eisai to Present Data on Oncology Pipeline and Products at ASCO20 Annual Meeting